Friend or Foe: Factor XII Deficiency Discovered Incidentally during Management of NSTEMI

TR Number

Date

2023-06-29

Journal Title

Journal ISSN

Volume Title

Publisher

Hindawi

Abstract

Factor XII (FXII) deficiency is a rare coagulopathy that typically goes undiagnosed due to the lack of abnormal bleeding or thrombosis. However, the accompanying prolonged activated partial thromboplastin time (aPTT) can create difficulties with maintaining therapeutic anticoagulation in the setting of acute coronary syndrome (ACS). Here, we present the case of a 52-year-old man presenting with chest pain and diagnosed with an NSTEMI but also found with a prolonged baseline aPTT ultimately secondary to FXII deficiency. Here, we discuss the diagnostic work-up of an isolated prolonged aPTT to identify possible etiologies, such as FXII deficiency, and ultimately inform ACS management.

Description

Keywords

Citation

Patrick J. Beck, John Benfield, and Joshua Morales, “Friend or Foe: Factor XII Deficiency Discovered Incidentally during Management of NSTEMI,” Case Reports in Hematology, vol. 2023, Article ID 5926340, 4 pages, 2023. doi:10.1155/2023/5926340